Amgen

Open: 227.31 Close: 229.18 Change: 1.87

You're losing the opportunity of using an AI to get informed about Amgen.

Are looking for the most relevant information about Amgen? Investor spend a lot of time searching for information to make investment decisions in Amgen. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, create, treatment, Nobel, laureate, close, move, and the most common words in the summary are: amgen, market, stock, event, news, price, company, . One of the sentences in the summary was: Amgen closed at $229.66, marking a +0.53% move from the previous day. Other searches …

Concept Map

Semantic Network

Stock Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's products include Enbrel, Prolia, Xgeva, Otezla, Aranesp, and Repatha..

Today's Summary

Amgen closed at $229.66, marking a +0.53% move from the previous day. Amgen share price has underperformed the S&P500 Index by -17.98% over the past year.

Today's News

Amgen makes money by creating treatments for medical conditions affecting millions. Company faces increasing competition from generic products and biosimilar treatments. Amgen dedicated a mural to celebrate diversity that has gone into creating the modern biotech industry. Among those celebrated are Nobel laureate David Baltimore, Nobel laureate Fu-Kuen Lin and Mary-Claire King. Amgen secures full fda approval for leukaemia therapy blincyto - pharmaceutical technology. Amgen believes Blincy to has been reinforced as standard of care for patients with MRD. Amgen Inc. (NASDAQ:AMGN) Shares Could Be 44% Below Their Intrinsic Value Estimate Key Insights Amgens estimated fair value is US$394. Amgen (AMGN) closed at $229.66, marking a +0.53% move from the previous day. Amgen rose more than any other stock, but Intel led the index lower. Amgen closed the most recent trading day at $229.66, moving +0.53% from the previous trading session. Investors will be hoping for strength from Amgen as it approaches its next earnings release. Amgen is projected to report earnings of $4.46 per share, which would represent a year-over-year decline. Amgen share price has underperformed the S&P500 Index by -17.98% over the past year. Amgen paid a total dividend of $7.95 last year, and it currently has a trailing dividend yield of 3.5%.

Stock Profile

"Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California."

Keywords

The game is changing. There is a new strategy to evaluate Amgen fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, create, treatment, Nobel, laureate, close, move, and the most common words in the summary are: amgen, market, stock, event, news, price, company, . One of the sentences in the summary was: Amgen closed at $229.66, marking a +0.53% move from the previous day. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #amgen #market #stock #event #news #price #company.